Low-dose aspirin may limit cancer metastasis by inhibiting platelet activation and enhancing T-cell immunity, supporting biomarker guided use while balancing bleeding risk overall.

Scientists are closer to understanding how an everyday painkiller can help our bodies fight cancer. The findings may offer a complementary mechanism for preventing the development and progression of ...

Longer follow-up of the ASPREE cohort is warranted, says researcher ...

An international research team headed by scientists at the University of Cambridge has uncovered a mechanism that may underpin how aspirin could reduce the metastasis of some cancers by preventing an ...

A follow-up study suggests that aspirin therapy does not reduce cancer risk in older adults, but may instead increase cancer-related mortality risk.

Long-term daily use of aspirin can help to prevent the development and progression of colorectal cancer, but the mechanisms involved have been unclear. New research has revealed that aspirin may exert ...

Interindividual Response Variability, Laboratory Variability or Aspirin 'Resistance'? Individual drug response is a multifactorial, highly variable trait, being the final phenotypic result of ...

Long-term daily use of aspirin can help to prevent the development and progression of colorectal cancer (CRC) but the mechanisms involved have been unclear. New research headed by investigators at the ...

Even a tiny bruise can reveal aspirin's powerful effects. The same heart-protecting action that prevents clots can make your skin a little more fragile, proving that with medicine, every benefit comes ...

Research has shown aspirin use to be associated with lower rates of metastasis for some patients. Aspirin use may be associated with lower rates of metastasis among patients with esophageal and ...